HEOR Staff Writer

NICE Endorses Darolutamide Prostate Cancer Treatment for Improved Patient Access

Promising PSMA-Targeted Therapy Delays Prostate Cancer Progression

Cabotegravir HIV Prevention: First Injectable PrEP Recommended for High-Risk ...

Johnson & Johnson Advances Solid Tumor Research at ESMO 2025 with Promis...

Colorectal Cancer Markers: Discovering Region-Specific Drivers for Precision ...

Evolving Burden of Obesity in the US: Key Insights on Obesity Prevention Stra...